TY - JOUR
T1 - Autoradiography of receptor-activated G-proteins in post mortem human brain
AU - Rodríguez-Puertas, R.
AU - González-Maeso, J.
AU - Meana, J. J.
AU - Pazos, A.
N1 - Funding Information:
This study was supported by grants from the Basque Government (PI98/8) and the University of the Basque Country (G13/98) to J.J.M., and from the CICYT (SAF98-0064-CO2-01) to A.P.; J.G.-M. is the recipient of an MEC predoctoral fellowship. R.R.-P. is the recipient of a Basque Government postdoctoral fellowship. We wish to thank the members of staff of the Instituto Anatómico Forense (Bilbao) and the Service of Pathological Anatomy of the “Marqués de Valdecilla” Hospital (Santander) for their cooperation. The technical assistance of Ms Lourdes Lanza and Ms Josefa Castillo is kindly acknowledged. We thank Ms Susana Mato for providing the autoradiographic illustration of [ 3 H]CP55940 binding.
PY - 2000/1
Y1 - 2000/1
N2 - The agonist-stimulated guanosine 5'-(γ-[35S]thio)triphosphate binding assay was used to anatomically localize receptor-activated G-proteins by autoradiography in post mortem human brain. The optimal conditions for guanosine 5'-(γ-[35S]thio)triphosphate binding to human brain sections were established in post mortem samples of the prefrontal cortex, hippocampus, basal ganglia, brainstem and cerebellar cortex. An excess of GDP (2mM) was required to decrease basal activity and obtain effective stimulation by specific agonists. guanosine 5'-(γ-[35S]Thio)triphosphate binding was increased after stimulation with specific agonists of different G-protein-coupled receptors. They include cannabinoid (WIN55212-2), μ-opioid ([D-Ala2,N-Me-Phe4,Gly5-ol]enkephalin), serotonin-1A [(±)-8-hydroxy-2-(di-n-propylamino)tetralin] and serotonin-1B/1D (sumatriptan), cholinergic muscarinic receptors (carbachol) and α2-adrenoceptors (UK14304). Such stimulation reached 1458%, 440%, 188%, 219%, 61% and 339%, respectively, over the basal levels. In tissue sections, the use of the above-mentioned agonists (10-4M) showed patterns of anatomical distribution similar to those already described by receptor autoradiography, with high densities over the hippocampus (serotonin-1A receptors), cortex (α2-adrenoceptors) and striatum (μ-opioid receptors). The highest binding levels were reached with the cannabinoid receptor agonist in most of the analysed brain regions. Carbachol produced only moderate stimulation of those same regions. The blockage of agonist-stimulated guanosine 5'-(γ-[35S]thio)triphosphate binding by selective antagonists verified that the effect was receptor mediated.This technique provides a method to identify modifications of the receptor-mediated activation of G-proteins in post mortem human brain with anatomical resolution. It also provides valuable information on the level of drug efficacy in the human species. Copyright (C) 1999 IBRO.
AB - The agonist-stimulated guanosine 5'-(γ-[35S]thio)triphosphate binding assay was used to anatomically localize receptor-activated G-proteins by autoradiography in post mortem human brain. The optimal conditions for guanosine 5'-(γ-[35S]thio)triphosphate binding to human brain sections were established in post mortem samples of the prefrontal cortex, hippocampus, basal ganglia, brainstem and cerebellar cortex. An excess of GDP (2mM) was required to decrease basal activity and obtain effective stimulation by specific agonists. guanosine 5'-(γ-[35S]Thio)triphosphate binding was increased after stimulation with specific agonists of different G-protein-coupled receptors. They include cannabinoid (WIN55212-2), μ-opioid ([D-Ala2,N-Me-Phe4,Gly5-ol]enkephalin), serotonin-1A [(±)-8-hydroxy-2-(di-n-propylamino)tetralin] and serotonin-1B/1D (sumatriptan), cholinergic muscarinic receptors (carbachol) and α2-adrenoceptors (UK14304). Such stimulation reached 1458%, 440%, 188%, 219%, 61% and 339%, respectively, over the basal levels. In tissue sections, the use of the above-mentioned agonists (10-4M) showed patterns of anatomical distribution similar to those already described by receptor autoradiography, with high densities over the hippocampus (serotonin-1A receptors), cortex (α2-adrenoceptors) and striatum (μ-opioid receptors). The highest binding levels were reached with the cannabinoid receptor agonist in most of the analysed brain regions. Carbachol produced only moderate stimulation of those same regions. The blockage of agonist-stimulated guanosine 5'-(γ-[35S]thio)triphosphate binding by selective antagonists verified that the effect was receptor mediated.This technique provides a method to identify modifications of the receptor-mediated activation of G-proteins in post mortem human brain with anatomical resolution. It also provides valuable information on the level of drug efficacy in the human species. Copyright (C) 1999 IBRO.
KW - 5-HT receptors
KW - Cannabinoid receptors
KW - Cholinergic muscarinic receptors
KW - [S]GTPγS binding
KW - α-adrenoceptors
KW - μ-opioid receptors
UR - http://www.scopus.com/inward/record.url?scp=0342679997&partnerID=8YFLogxK
U2 - 10.1016/S0306-4522(99)00527-8
DO - 10.1016/S0306-4522(99)00527-8
M3 - Article
C2 - 10683421
AN - SCOPUS:0342679997
SN - 0306-4522
VL - 96
SP - 169
EP - 180
JO - Neuroscience
JF - Neuroscience
IS - 1
ER -